Related Experiment Videos
Antisperm antibodies and male subfertility
1Royal Marsden Hospital, London, UK.
British Journal of Urology
|December 11, 1997
Summary
Treating male immunological infertility requires balancing risks, costs, and success timelines. Steroid treatment shows promise but predicting patient response is crucial for effective management of infertility.
Area of Science:
- Reproductive Medicine
- Immunology
- Andrology
Background:
- Male immunological infertility presents complex challenges for couples seeking conception.
- Treatment decisions necessitate careful consideration of risks, costs, and potential success rates.
- Identifying reversible factors is a key initial step in managing male infertility.
Purpose of the Study:
- To evaluate treatment outcomes for male immunological infertility.
- To emphasize the importance of predicting treatment response, particularly for steroid therapy.
- To outline various treatment strategies and their integration.
Main Methods:
- Review of current treatment options for male immunological infertility.
- Discussion of steroid treatment efficacy and limitations.
- Exploration of assisted reproductive technologies like IUI, IVF, and ICSI.
Main Results:
- Steroid treatment is a viable option but fails in approximately two-thirds of patients.
- Predicting responders to steroid treatment is essential to optimize outcomes.
- Success of Intrauterine Insemination (IUI) can be improved with advanced sperm preparation.
- In vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) are options for severe cases or when other factors are present.
Conclusions:
- Treatment for male immunological infertility requires a comprehensive approach.
- Predictive markers for treatment success, especially for steroids, need further investigation.
- Assisted reproductive technologies offer valuable alternatives when initial treatments are unsuccessful or for severe infertility.